- Home
- TPST vs IINN Comparison
TPST vs IINN Comparison
Compare TPST & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- IINN
- Stock Information
- Founded
- TPST 2011
- IINN 2018
- Country
- TPST United States
- IINN Israel
- Employees
- TPST N/A
- IINN N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- IINN Medical/Dental Instruments
- Sector
- TPST Health Care
- IINN Health Care
- Exchange
- TPST Nasdaq
- IINN Nasdaq
- Market Cap
- TPST 27.2M
- IINN 25.9M
- IPO Year
- TPST N/A
- IINN 2021
- Fundamental
- Price
- TPST $0.93
- IINN $1.06
- Analyst Decision
- TPST Strong Buy
- IINN
- Analyst Count
- TPST 4
- IINN 0
- Target Price
- TPST $20.00
- IINN N/A
- AVG Volume (30 Days)
- TPST 1.8M
- IINN 1.8M
- Earning Date
- TPST 11-12-2024
- IINN 08-15-2024
- Dividend Yield
- TPST N/A
- IINN N/A
- EPS Growth
- TPST N/A
- IINN N/A
- EPS
- TPST N/A
- IINN N/A
- Revenue
- TPST N/A
- IINN N/A
- Revenue This Year
- TPST N/A
- IINN N/A
- Revenue Next Year
- TPST N/A
- IINN N/A
- P/E Ratio
- TPST N/A
- IINN N/A
- Revenue Growth
- TPST N/A
- IINN N/A
- 52 Week Low
- TPST $0.70
- IINN $0.80
- 52 Week High
- TPST $6.00
- IINN $2.45
- Technical
- Relative Strength Index (RSI)
- TPST 54.03
- IINN 46.38
- Support Level
- TPST $0.86
- IINN $1.00
- Resistance Level
- TPST $1.05
- IINN $1.11
- Average True Range (ATR)
- TPST 0.08
- IINN 0.11
- MACD
- TPST 0.01
- IINN 0.01
- Stochastic Oscillator
- TPST 52.92
- IINN 67.27
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.